Search

• GSK and ViiV Healthcare to present scientific advancements in their industry-leading infectious diseases portfolio at IDWeek 2023

  Media

  First scientific presentation of RSV vaccine efficacy and safety data over two seasons.

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-viiv-healthcare-to-present-scientific-advancements-at-idweek-2023/

  First published: 10 October 2023

• GSK signs agreement to support pandemic preparedness in Europe

  Media

  GSK will supply Adjupanrix to 12 participating European countries.

  https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-to-support-pandemic-preparedness-in-europe/

  First published: 28 July 2022

• GSK appoints Phil Dormitzer M.D., Ph.D., as Global Head of Vaccines R&D

  Media

  Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3 December 2021

  https://www.gsk.com/en-gb/media/press-releases/gsk-appoints-phil-dormitzer-md-phd-as-global-head-of-vaccines-rd/

  First published: 30 November 2021

• 

  ‘Adult vaccination plays an essential role in healthy ageing, so let’s prioritise prevention and make it a new standard of care’

  Behind the science magazine

  Adult immunisation can help people live longer, healthier lives and continue to make vital contributions to society

  https://www.gsk.com/en-gb/behind-the-science-magazine/adult-vaccines-healthy-ageing-comment/

  First published: 04 December 2023

• 

  Vaccinations are not just for children: why adult immunisation is a health and economic necessity

  Behind the science magazine

  As the global population ages, innovative health policy is needed to ensure adults are vaccinated against potentially dangerous diseases.

  https://www.gsk.com/en-gb/behind-the-science-magazine/vaccinations-children-adult-immunisation-health-economic-benefits/

  First published: 21 March 2025

• GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults

  Media

  17 abstracts to evaluate unmet medical need and approaches to RSV prevention in adults.

  https://www.gsk.com/en-gb/media/press-releases/gsk-to-showcase-latest-research-at-the-international-rsv-symposium-to-advance-rsv-prevention-in-adults/

  First published: 06 March 2025

• 

  The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact

  Behind the science magazine

  The flu, COVID-19, and RSV are all in circulation, raising the risk of severe infectious disease in older adults.

  https://www.gsk.com/en-gb/behind-the-science-magazine/tripledemic-flu-covid-rsv-older-patients-infectious-disease/

  First published: 04 January 2023

• GSK opens new global vaccines R&D center in Rockville, MD, USA

  Media

  New state-of-the-art facility will house 450 scientists and support staff, creating up to 200 new jobs.

  https://www.gsk.com/en-gb/media/press-releases/gsk-opens-new-global-vaccines-rd-center-in-rockville-md-usa/

  First published: 13 December 2016

• GSK announces results from 17-year retrospective study on US clinical trial diversity

  Media

  Study examined clinical trial diversity across 495 GSK trials involving over 100,000 participants.

  https://www.gsk.com/en-gb/media/press-releases/gsk-announces-results-from-17-year-retrospective-study-on-us-clinical-trial-diversity/

  First published: 06 February 2023

• 

  Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk

  Behind the science magazine

  GSK scientists spent decades researching respiratory syncytial virus to understand better how to prevent the disease

  https://www.gsk.com/en-gb/behind-the-science-magazine/rsv-symptoms-risks-protection/

  First published: 10 March 2025